Senator Kim Pushes for Comprehensive Research and Treatment Options During Nomination Hearing for Health and Human Services Secretary
WASHINGTON D.C.–Today,Senator Andy Kimaddressed top public health concerns including addiction prevention and treatment, vaccine access and development, and research around gun deaths during the Senate Committee on Health, Education, Labor, and Pensions’ Nomination Hearing for U.S. Secretary of Health and Human Services nominee, Robert F. Kennedy Jr. Kim began his question line on a top priority for New Jersey and our country, combating the opioid crisis and saving lives with expanded treatment options, including medication-assisted treatment (MAT).
Video of Question Line
“I know we all take this very seriously, in terms of the plight of opioid addiction in our country and that is something I hope we can recognize that we need to lift up more and more…”said Senator Kim.“In fact, an NIH published study does call [MAT] the gold standard of treatment for opioid use disorder.”
As a member of the House of Representatives, Kim prioritized expanding access to opioid treatment to prevent addition-related deaths, including as a co-sponsor of the bipartisan Mainstreaming Addiction Treatment Act, which became law in 2022, to expand access to MAT and expand healthcare providers’ treatment options for substance use disorder.
Senator Kim is a member of the Senate Committee on Commerce, Science, and Transportation; Committee on Banking, Housing, and Urban Affairs; Committee on Health, Education, Labor, and Pensions (HELP); Committee on Homeland Security and Governmental Affairs; and the Special Committee on Aging. Learn more about Senator Kim’s service on behalf of New Jerseyhere.
Hart Senate Office BuildingSuite 520Washington, D.C. 20510
Phone: (202) 224-4744
210 Hudson StreetHarborside 3, Suite 1000Jersey City, NJ 07311
Phone: (201) 377-0900
208 White Horse PikeSuite 18Barrington, NJ 08007
Phone: (856) 757-5353
991804f5-6fa6-4fe7-b54b-1481f31e5288Issued within 24 hours
Other senators' releases published in the day before or after this one.